enantio PAF C-16

1-hexadecyl-2-acetyl-glycero-3-phosphocholine

2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate

2-Acetoxy-3-(hexadecyloxy)propyl-2-(trimethylammonio)ethylphosphat

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

77286-68-1

enantio PAF C-16

Ethanaminium, 2-[[[2-(acetyloxy)-3-(hexadecyloxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt

Phosphate de 2-acétoxy-3-(hexadécyloxy)propyle et de 2-(triméthylammonio)éthyle

(2-acetyloxy-3-hexadecoxypropyl) 2-trimethylazaniumylethyl phosphate

1-O-HEXADECYL-2-ACETYL-RAC-GLYCERO-3-PHOSPHOCHOLINE

1-O-Palmityl-2-acetyl-rac-glycero-3-phosphocholine

1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine

117985-57-6

1b{2-[(2-Acetoxy-3-hexadecyloxy-propoxy)-hydroxy-phosphoryloxy]-ethyl}-trimethyl-ammonium

2-(acetyloxy)-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate

65154-06-5

74389-68-7

7787-42-0

APRL

enantio platelet-activating factor C-16

Enantio-PAF C-16

Enantio-PAFC-16

MFCD00043214

PAF (C16)

phospho(2-hexadecyloxy-1-methylethyl acetate)-ethylammonium

PLATELET ACTIVATING FACTOR

platelet activating factor(PAF)

Platelet Activating Factor-16

{2-[(2-Acetoxy-3-hexadecyloxy-propoxy)-hydroxy-phosphoryloxy]-ethyl}-trimethyl-ammonium